Thursday, March 23, 2023

AdvocateHealthyu

advocatehealthyu.com
AdvocateHealthyu
advocatehealthyu.com
  • Health News
  • Personal Health
  • Health Problems
  • Medications
  • Family Health
  • Kids Health
  • Beauty & Balance

Home » Health News » Evaluating local impedance-based mapping to improve characterization of ventricular tachycardia substrate

Health News

Evaluating local impedance-based mapping to improve characterization of ventricular tachycardia substrate

Forest Hayes February 21, 2023

Innovative technique to improve characterisation of ventricular tachycardia substrate
Source: Read Full Article

Related posts:
  1. This type of yoga will do wonders for your anxiety
  2. New Rules for Vaccinated People, Troops Enforce Lockdown: COVID-19 Global Weekly Highlights
  3. When did you get your second Covid vaccine dose? You may be ‘worse off’ to Delta variant
  4. Dementia: What you do while you sit may affect your risk

Post navigation

Previous Previous post: Kelly Osbourne Vulnerably Documents the Challenging Transition Back to Work After Having Her Baby
Next Next post: Boy told he was ‘constipated’ turned out to have cancer
Personal Health

A $30 Million Gift to Build an Addiction Treatment Center. Then Staffers Had to Run It.

DECATUR, Ill. — The question came out of the blue, or so it seemed to…

The Player-Coaches of Addiction Recovery Work Without Boundaries

CENTENNIAL, Colo. — Sarah Wright stops by her peer support specialist’s hotel room-turned-office in this…

Texas Revamps ‘Active-Shooter’ Drills at K-12 Schools to Minimize Trauma

AUSTIN, Texas — After Britt Kelly’s son participated in a lockdown drill two years ago…

Medications

Despite Pharma Claims, Illicit Drug Shipments to US Aren’t Full of Opioids. It’s Generic Viagra.

For years, the FDA has defended its efforts to intercept prescription drugs coming from abroad…

U.S. FDA Approves Takeda’s Takhzyro (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older

Takhzyro is the First and Only Prophylaxis Treatment Approved in the U.S. for Children 2…

Eylea (aflibercept) Injection Approved as the First Pharmacologic Treatment for Preterm Infants with Retinopathy of Prematurity (ROP) by the FDA

ROP is a leading cause of childhood blindness worldwide Eylea now approved to treat five…

Health News

Microwave Ablation Alternative to Surgery for T2 Breast Tumors

The study covered in this summary was published on researchsquare.com as a preprint and has…

Memory B cell marker predicts long-lived antibody response to flu vaccine

Memory B cells play a critical role to provide long-term immunity after a vaccination or…

Man grows staggering 18 inches after doctors remove brain tumour

We use your sign-up to provide content in ways you’ve consented to and to improve…

AdvocateHealthyu | © Copyright All right reserved
Top